Mylan launches generic Actonel tablets

PITTSBURGH — Mylan on Wednesday announced the launch of risedronate sodium tablets USP, 150 mg. The drug is the generic version of Actonel tablets from Warner Chilcott and is used for the treatment of osteoporosis in post-menopausal women, according to the company.

Risedronate sodium tablets USP had sales in the United States of $171.6 million for the 12 months ending March 31, 2014, according to IMS Health.

Login or Register to post a comment.